Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pinocembrin injection in acute ischemic stroke (phase II)
CTR20130155Phase 2Active
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pinocembrin in ischemic stroke, sponsored by CSPC Pharmaceutical Group. Started Apr 2014; status: active.
02
Drugs
pinocembrin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20130155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130155.